Form 4: Perrigo Executive Receives Stock Units in Latest SEC Filing
SEC Form 4 Filing
David Ball, EVP & CBDO of Perrigo Co plc, reports the acquisition of 15,402 restricted stock units in a recent SEC Form 4 filing.
Summary
- An SEC Form 4 filing reveals that David Ball, Executive Vice President and Chief Brand and Digital Officer (CBDO) of Perrigo Company plc, was granted 15,402 restricted stock units (RSUs) on September 9, 2024.
- Each RSU represents a contingent right to receive one ordinary share of Perrigo Company plc.
- The RSUs vest in two equal annual installments, beginning on September 9, 2025.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and indicates confidence in the executive's future contributions. It's a routine filing, but positive for aligning executive and shareholder interests.
Positives
- The grant of RSUs to a key executive like David Ball can be seen as an incentive to align his interests with those of the shareholders.
Future Outlook
The RSUs will vest in two equal annual installments beginning September 9, 2025, indicating a commitment to the company's future performance.
Industry Context
Granting stock-based compensation is a common practice in the pharmaceutical and consumer healthcare industries to attract and retain top talent and align their interests with shareholder value.
Comparison to Industry Standards
- Stock grants are a typical component of executive compensation packages in the pharmaceutical industry, often benchmarked against peer companies like Teva, Mylan (now Viatris), and Johnson & Johnson.
- The vesting schedule of two years is fairly standard, aligning with typical retention incentives.
- The number of RSUs granted would be evaluated in the context of Perrigo's overall compensation strategy and the executive's role and responsibilities compared to similar positions at comparable companies.
Stakeholder Impact
- The RSU grant aligns the executive's interests with those of shareholders, incentivizing him to increase shareholder value.
- Employees may view the RSU grant positively, as it signals the company's investment in its leadership.
Key Dates
| Date | Description |
|---|---|
| August 2024 | Date of Power of Attorney execution. |
| 09/09/2024 | Date of transaction: Grant of 15,402 Restricted Stock Units. |
| 09/09/2025 | First vesting date for the Restricted Stock Units. |
| 09/10/2024 | Date of signature for the SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.